St. Cloud Financial Credit Union holds over 20 Bitcoin in custody for its members using a patented hybrid multisignature vault system that ensures individual ownership and requires multiple keys for transactions. CEO Jed Meyer highlighted this model's security and discussed future plans including direct Bitcoin trading and Lightning Network integration. The interview also covered regulatory aspects, stablecoins, and how credit unions select digital assets, comparing their custody approach to Bitcoin ETFs. This innovative custody approach aims to integrate digital assets safely into credit union services and ownership structures.
The story on St. Cloud Financial Credit Union's Bitcoin custody offers context for cryptocurrency market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 07, 2026 04:41 WIB: out of 50 major cryptocurrencies, 9 rose and 40 fell today. Notable price changes include BAL at Rp16.297 with a +11.14% increase and EOS at Rp12.649 with a +8.13% increase.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
U.S. spot Solana ETFs experienced $3.7 million in net outflows on October 6, marking the second consecutive day of withdrawals. The Grayscale Solana Trust was the main contributor to this decline, while six other funds showed no net flow. Although th...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
